Sanger Sequencing Service Market is expected to reach US$ 1,360.47 Mn by 2027

PRESS RELEASE BY The Insight Partners 27 Nov 2019

Share this press on

The Sanger sequencing service market size expected to reach US$ 1,360.47 Mn by 2027, registering at a CAGR of 12.2% during the forecast period 2019 - 2027, according to a new research study conducted by The Insight Partners.

Biomarkers and cancer segment is expected to grow the market for Sanger sequencing service over the forecast period among the application.


The report highlights the trends prevalent in the global Sanger sequencing service market and the factors driving the market along with those that act as deterrents to its growth.


The global Sanger sequencing service market, based on application, was segmented as, diagnostics, biomarkers and cancer, reproductive health, personalized medicine, forensics, and other applications. In 2018 biomarkers and cancer held the largest share of the market, by application, due to the rising incidence of cancer, increasing the use of cancer biomarkers in drug discovery and diagnostics, and increasing research on cancer biomarkers.


The market for Sanger sequencing service is expected to grow owing to factors such as increasing providers for Sanger sequencing services and growing applications of Sanger sequencing. Also, an increase in the number of startup companies for genome analysis is expected to have a positive impact on the growth of the market in the coming years.


The major players operating in the Sanger sequencing service market include Microsynth AG, Laragen, Inc., StarSEQ GmbH, Thermo Fisher Scientific, Inc., LGC Biosearch Technologies, Fasteris SA, Quintara Biosciences, GENEWIZ, GenScript, and SciGenom Labs among others. The market of Sanger sequencing service has witnessed various organic developments during recent years. During September 2019, GENEWIZ, a Brooks Life Sciences Company, declared the opening of its European headquarters for its genomics business in Germany. The facility will provide onsite Sanger sequencing and next-generation sequencing services.


Global Sanger Sequencing Service Market, By Regions, 2018 (%)

Sanger Sequencing Service Market Size, Share Report 2027

Download Free Sample

Published Report - Sanger Sequencing Service Market to 2027 - Global Analysis and Forecasts by Application (Diagnostics, Biomarkers and Cancer, Reproductive Health, Personalized Medicine, Forensics, and Other Applications); End User (Academic and Government Research Institutes, Biotechnology & Pharmaceutical Companies, Hospitals and Clinics, and Other End Users), and Geography

The report segments the Global Sanger Sequencing Service Market as follows:


Global Sanger Sequencing Service Market – By Application

  • Diagnostics
  • Biomarkers and Cancer
  • Reproductive Health
  • Personalized Medicine
  • Forensics
  • Other Applications

Global Sanger Sequencing Service Market – By End User

  • Academic and Government Research Institutes
  • Biotechnology Companies and Pharmaceutical Companies
  • Hospitals and Clinics
  • Other End Users

Global Sanger Sequencing Service Market – By Geography

  • North America
    • US
    • Canada
    • Mexico
  • Europe
    • France
    • Germany
    • U.K
    • Spain
    • Italy
  • Asia Pacific (APAC)
    • China
    • India
    • Japan
    • Australia
    • South Korea
  • Middle East & Africa (MEA)
    • Saudi Arabia
    • U.A.E
    • South Africa
  • South & Central America (SCAM)
    • Brazil
    • Argentina


Contact Us

Phone: +1-646-491-9876

Email Id:


Download Free PDF Brochure